AI News NQ Analysis

Awareness Survey on Doctor-Patient Communication Regarding Valvular Heart Disease in Japan

NQ Score 100/100

AI Summary (NQ-processed)

Edwards Lifesciences conducted a survey of 1,690 people aged 65 and older and cardiovascular physicians regarding valvular heart disease understanding and clinical communication. The results reveal that while heart health awareness is high, there is limited understanding that valvular heart disease symptoms are easily mistaken for aging, leading to delayed medical consultation. Furthermore, both patients and physicians report significant challenges in communicating symptoms and discussing treatment options, highlighting the need for better support in the clinical setting.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What brand conducted the valvular heart disease awareness survey involving 1,690 participants in Japan?
A: Edwards Lifesciences conducted the survey on valvular heart disease awareness in Japan.
Q: How many people aged 65 and older were surveyed by Edwards Lifesciences in Japan regarding heart disease?
A: Edwards Lifesciences surveyed 1,690 people aged 65 and older in Japan.
Q: What specific heart condition was the focus of Edwards Lifesciences' awareness survey in Japan?
A: The survey by Edwards Lifesciences focused on valvular heart disease in Japan.
Q: Why do some patients delay seeking medical help for valvular heart disease according to the Edwards Lifesciences survey?
A: Patients delay consultation because valvular heart disease symptoms are often mistaken for aging.
Q: What challenge do both physicians and patients face in Japan according to the Edwards Lifesciences survey results?
A: Both physicians and patients report difficulties in discussing valvular heart disease symptoms and treatments.